Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Gary S. Gillheeney, Sr$369.5M
Market Cap • 17/04/20242018
(há 6 anos)
2016
(8 years ago)
NASDAQ
Listagem
Canton
Sede • Massachusetts1.030
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ORGOSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.